BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2019
View Archived Issues
Taurolidine demonstrates efficacy in preclinical pediatric neuroblastoma studies
Read More
General protein synthesis inhibition in specific cells
Read More
Novel model of inflammatory enterocutaneous fistulas by transplantation of human fetal gut into mice
Read More
Phase I trial of nivolumab, alone or in combination, for unresectable/recurrent biliary tract cancer
Read More
Johnson & Johnson launches international research consortium to advance TB antibiotics
Read More
Patient enrollment ongoing in phase I/II study of DZD-9008 in NSCLC with EGFR or HER2 mutation
Read More
Positive phase III data presented from CHIASMA OPTIMAL study of Mycapssa
Read More
NLGN-1 as a potential new biomarker of synaptic loss in Alzheimer's disease
Read More
FGF-21 identified as a marker of islet function after transplantation
Read More
Roystonea regia lipid extract reduces lower urinary tract symptoms in men with BPH
Read More
Roche describes antibodies targeting vascular endothelial growth factor A
Read More
Sanford Burnham Prebys Medical Discovery Institute patents ACP1 inhibitors
Read More
TILRR is a new therapeutic target for treating vaginal HIV-1 infection
Read More
Indoleamine 2,3-dioxygenase 1 inhibitors identified at Bristol-Myers Squibb
Read More
Metallo-beta-lactamase inhibitors synthesized at Merck & Co.
Read More
Impetis Biosciences discovers adenosine A2A and/or A2B receptor antagonists
Read More
Activation of neuronal TRPV1 is sufficient to cause the equivalent of psoriasis
Read More
Novel pigenin derivative with anti-ischemic and neuroprotective effects following ischemia in rats
Read More
First results presented for reparixin in pancreatic islet transplantation in type 1 diabetes
Read More
Phase III OPTIMUM study of ponesimod in relapsing MS meets primary endpoint
Read More
Abeona announces interim data from phase I/II study of ABO-102 gene therapy for MPS IIIA
Read More
Aptevo advances clinical trials of APVO-210 and APVO-436
Read More
Researchers test nanochannel delivery implant for HIV drug cabotegravir
Read More
Seattle Genetics begins phase I trial of SGN-CD47M in advanced solid tumors
Read More
Inhibrx studies INBRX-101 in patients with alpha1-antitrypsin deficiency in new phase I trial
Read More